PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Octagon Research Solutions, Inc. Announces New Agreement with Leading Pharmaceutical Company - Octagon Research Solutions, Inc., announced today that the company has executed an agreement with Wyeth Pharmaceuticals to begin using ViewPoint®, Octagon’s Enterprise Submission Process Management Solution.
Octagon Research Solutions, Inc. Announces New Agreement with Leading Pharmaceutical Company

 

NewswireToday - /newswire/ - Wayne, PA, United States, 2006/08/02 - Octagon Research Solutions, Inc., announced today that the company has executed an agreement with Wyeth Pharmaceuticals to begin using ViewPoint®, Octagon’s Enterprise Submission Process Management Solution..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D to the life sciences industry, announced today that the company has executed an agreement with Wyeth Pharmaceuticals, a division of Wyeth [NYSE:WYE}, one of the world’s largest research-driven pharmaceutical and health care products companies, to begin using ViewPoint®, Octagon’s Enterprise Submission Process Management Solution, for managing complex, cross-functional processes in support of regulatory submissions.

Jim Walker, chairman and CEO of Octagon stated, “We are pleased and honored that our ViewPoint product is going to be used by Wyeth Pharmaceuticals. Wyeth has always been a forward thinking and progressive company and the fact that they chose Viewpoint to help with their processes makes us very proud as a company. I am looking forward to building upon this relationship.”

Octagon’s ViewPoint® facilitates communication, planning and management of complex processes. It provides real-time metrics, reporting and search capabilities to answer process questions. ViewPoint also enables users to manage content, resources, tasks and issues across the entire submission lifecycle.

In Wyeth’s case, ViewPoint will enable Wyeth’s Global Regulatory Affairs (GRA) to effectively communicate within and across project teams and departments regarding project information, provide visibility across business units on related projects and activities, track and manage a variety of regulatory projects and processes, and use ViewPoint’s Regulatory Dashboard to provide GRA real-time, daily views of information for all projects and processes. At Wyeth, 22 Regulatory business processes have been documented and configured within ViewPoint and 30+ training sessions are to be administered by Octagon professionals over the coming weeks.

ViewPoint will also support GRA’s process for tracking and managing workload and resources. Using an accurate content plan with the associated task benchmarks, the GRA team can use ViewPoint’s Project Estimator tool to project resources and workload required to complete the project.

During the course of executing the project and processes, ViewPoint will be capturing data to enable GRA to produce and report on metrics as well as to track regulatory and submission management activities. In addition, ViewPoint will provide reports that support GRA in getting project status information as well as compiling real-time metrics during the wrap-up of the submission project.

Kirk Gallion, Octagon’s president added, “Gina Schmidt, assistant vice president, Global Regulatory Submissions Management, Global Regulatory Affairs, and her entire Global Regulatory Affairs team at Wyeth have a vision to become the industry leader in effectively managing submission processes. I believe they are positioned for success as they use ViewPoint to initiate, manage, and report on all submission processes from original marketing applications to their daily maintenance submissions.”

About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and integrated solutions. Octagon is headquartered in Wayne, PA, with offices in Boston, MA, Costa Mesa, CA, and European headquarters in Amersham, UK.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Octagon Research Solutions, Inc. Announces New Agreement with Leading Pharmaceutical Company

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jim Graham 
610 535 6500 5655 jgraham[.]octagonresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Octagon Research Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)